Registration for IAS 2021 – the 11th IAS Conference on HIV Science – is now open. Register today and join thousands of HIV professionals at the world’s most influential virtual meeting on HIV research from 18-21 July 2021.
Early registration closes 31 March 2021 - https://ias2021.org/registration/
Bring your science to IAS 2021 to present your new ideas, concepts and research on a global virtual platform. Abstracts will be accepted until 15 February 2021 - https://www.ias2021.org/abstracts/
The International Scholarship Programme is open to everyone around the world working or volunteering in the field of HIV. Take part and apply before 26 February 2021 - https://www.ias2021.org/scholarships/
The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible. The Global Forum program addresses the full spectrum of issues relevant to TB vaccine research and development (R&D), from basic research to clinical trials, manufacturing, regulatory, access, and advocacy.
Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines will be convened from 20 - 22 April 2021. It will provide an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convene researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.
To register visit https://tbvaccinesforum.org/register/
The remarkably rapid development of the COVID-19 vaccine has fueled enthusiasm about ending the pandemic. Yet, many questions remain elusive. Keep pace with this evolving area and join the COVID-19 Vaccine Development & Implementation Workshop 2021 from 16 - 17 February. You will hear about the current understanding of vaccine-provided protection, how emerging variants should be monitored, and which approach to take in order to get the maximum public health benefit out of the current vaccination programs.
Registration is open and complimentary for non-industry participants - https://virology.eventsair.com/covid-vaccine-feb-2021/registration/Site/Register